Skip to main content
Article thumbnail
Location of Repository

Effect of Lactobacillus salivarius Bacteriocin Abp118 on the Mouse and Pig Intestinal Microbiota

By Eliette Riboulet-Bisson, Mark H. J. Sturme, Ian B. Jeffery, Michelle M. O'Donnell, B. Anne Neville, Brian M. Forde, Marcus J. Claesson, Hugh Harris, Gillian E. Gardiner, Patrick G. Casey, Peadar G. Lawlor, Paul W. O'Toole and R. Paul Ross

Abstract

Lactobacilli are Gram-positive bacteria that are a subdominant element in the human gastrointestinal microbiota, and which are commonly used in the food industry. Some lactobacilli are considered probiotic, and have been associated with health benefits. However, there is very little culture-independent information on how consumed probiotic microorganisms might affect the entire intestinal microbiota. We therefore studied the impact of the administration of Lactobacillus salivarius UCC118, a microorganism well characterized for its probiotic properties, on the composition of the intestinal microbiota in two model animals. UCC118 has anti-infective activity due to production of the bacteriocin Abp118, a broad-spectrum class IIb bacteriocin, which we hypothesized could impact the microbiota. Mice and pigs were administered wild-type (WT) L. salivarius UCC118 cells, or a mutant lacking bacteriocin production. The microbiota composition was determined by pyrosequencing of 16S rRNA gene amplicons from faeces. The data show that L. salivarius UCC118 administration had no significant effect on proportions of major phyla comprising the mouse microbiota, whether the strain was producing bacteriocin or not. However, L. salivarius UCC118 WT administration led to a significant decrease in Spirochaetes levels, the third major phylum in the untreated pig microbiota. In both pigs and mice, L. salivarius UCC118 administration had an effect on Firmicutes genus members. This effect was not observed when the mutant strain was administered, and was thus associated with bacteriocin production. Surprisingly, in both models, L. salivarius UCC118 administration and production of Abp118 had an effect on Gram-negative microorganisms, even though Abp118 is normally not active in vitro against this group of microorganisms. Thus L. salivarius UCC118 administration has a significant but subtle impact on mouse and pig microbiota, by a mechanism that seems at least partially bacteriocin-dependent

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3281923
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2007). A fivestrain probiotic combination reduces pathogen shedding and alleviates disease signs in pigs challenged with Salmonella enterica Serovar Typhimurium.
    2. (1960). A medium for the cultivation of lactobacilli.
    3. (2009). Alteration of the ileal microbiota of weanling piglets by the growth-promoting antibiotic chlortetracycline.
    4. (2007). Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118.
    5. (1995). Bacteriocins of gram-positive bacteria.
    6. (2010). Bacteroides spp. and diarrhea.
    7. (2011). Characterization and Scope of S-layer Protein O-Glycosylation in Tannerella forsythia.
    8. (2002). Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium Lactobacillus salivarius subsp. salivarius UCC118.
    9. (2006). Comparative and functional analysis of sortase-dependent proteins in the predicted secretome of Lactobacillus salivarius UCC118.
    10. (2011). Comparative fecal metagenomics unveils unique functional capacity of the swine gut.
    11. (2010). Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions.
    12. (1992). Conservation evaluation and phylogenetic diversity.
    13. (2012). Core Team (2011) R: A Language and Environment for Statistical Computing.
    14. (1993). Genetics of bacteriocins produced by lactic acid bacteria.
    15. (2006). Identification of a novel, invasive, not-yet-cultivated Treponema sp. in the large intestine of pigs by PCR amplification of the 16S rRNA gene.
    16. (1975). Improved medium for lactic streptococci and their bacteriophages.
    17. (2010). Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors.
    18. (1998). Inflammatory bowel disease: etiology and pathogenesis.
    19. (2010). Intestinal and immunological effects of daily oral administration of Lactobacillus salivarius CECT5713 to healthy adults.
    20. (2011). Isolation of Lactobacillus salivarius 1077 (NRRL B-50053) and characterization of its bacteriocin, including the antimicrobial activity spectrum.
    21. (2010). Lozniewski A
    22. (2011). Modulatory effects of Lactobacillus salivarius on intestinal mucosal immunity of piglets.
    23. (2006). Multireplicon genome architecture of Lactobacillus salivarius.
    24. (2010). Obesity and the human microbiome.
    25. (2009). Pediocin PA-1 and a pediocin producing Lactobacillus plantarum strain do not change the HMA rat microbiota.
    26. (2008). Predominance of a bacteriocin-producing Lactobacillus salivarius component of a five-strain probiotic in the porcine ileum and effects on host immune phenotype.
    27. (2011). Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07.
    28. (2005). Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius,i nt h e TNBS model of rat colitis.
    29. (2001). Probiotic bacteria enhance murine and human intestinal epithelial barrier function.
    30. (2008). Probiotic bacteria influence the composition and function of the intestinal microbiota. Interdiscip Perspect Infect Dis
    31. (2005). Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements.
    32. (1998). Probiotics.
    33. (2010). QIIME allows analysis of high-throughput community sequencing data.
    34. (2010). Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial.
    35. (2004). Relative ability of orally administered Lactobacillus murinus to predominate and persist in the porcine gastrointestinal tract.
    36. (2007). Salivaricin P, one of a family of two-component antilisterial bacteriocins produced by intestinal isolates of Lactobacillus salivarius.
    37. (2001). Selection of a potential probiotic Lactobacillus strain and subsequent in vivo studies.
    38. (2004). Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach.
    39. (1951). Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli.
    40. (2011). The activity of bacteriocins from Carnobacterium maltaromaticum UAL307 against gramnegative bacteria in combination with EDTA treatment.
    41. (1995). The genera of Lactic Acid Bacteria. London: Blackie Academic and Professional.
    42. (2008). The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing.
    43. (2009). The Ribosomal Database Project: improved alignments and new tools for rRNA analysis.
    44. (2005). UniFrac: a new phylogenetic method for comparing microbial communities.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.